A recent OIG report found that diagnoses reported in 2022 Medicare Advantage (MA) encounter data based only on health risk… ...

In a move that has woken the biomedical research community, the National Institutes of Health (NIH) announced on Friday, ...

Legal, Regulatory, and Compliance Issues ...

In a move that has woken the biomedical research community, the National Institutes of Health (NIH) announced on Friday, February… ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to ...

The year is 2030, you have been in the doctor's office for two hours, answering what seems like hundreds of questions on ...

In a recent episode of Oncology Unscripted, Dr. John Marshall, a renowned oncologist from Georgetown University, delves into ...

In one of the largest healthcare fraud cases in U.S. history, an Arizona couple has admitted to orchestrating a scheme that ...

Sandoz recently announced a $275 million settlement with its subsidiary Fougera Pharmaceuticals, to resolve allegations of ...

The year is 2030, you have been in the doctor's office for two hours, answering what seems like hundreds of questions on their… ...